Abstract
Radiofrequency ablation (RFA) is a relatively new technique for breast cancer treatment. In spite of the increasing literature about RFA, there is limited experience in breast cancer treatment. According to the results of a few clinical studies, even if RFA is preferable as a minimally invasive procedure in cases with localised small sized tumors (T1), there are a few obstacles to overcome. The studies have stated that the histopathological knowledge and information was lost by postablation damage and there is an absence of standardization of care in follow-up. In order to consider RFA as a treatment option in breast cancer, there is a need for long-term follow-up research studies including a higher number of patient enrollment.
Keywords:
Radiofrequency ablation, breast cancer, RFA
References
1
Fisher B, Redmond C, Poisson R et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989;320:822-828. [DOI:10.1097/ COC.0b013e3181c4c54b]
2
Veronessi U, Salvatori B, Luini A et al. Conserving treatment of early breast cancer: long term result of 1232 cases treated with quadranectomy,axillary dissection and radiotherapy. Ann Surg 1990;211:250-259.
3
Yamamoto N, Fujimoto H, Nakamura R et al. Pilot study of radiofrequency ablation therapy without surgical excision for T1 breast cancer: evaluation with MRI and vacuum-assisted core needle biopsy and safety management. Breast Cancer 2011;18:3-9.
4
Kinoshita T, Iwamoto E, Tsuda H et al. Radiofrequency ablation as local therapy for early breast carcinomas. Breast Cancer 2011;18:10-17.
5
Vrieling C, Collette L, Fourquet A et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Group Radiother Oncol 2000;55:219-232.
6
Bakker XR, Roumen RM. Bleeding after excision of breast lump. Eur J Surg 2002;168:401-403.
7
van Esser S, van den Bosch MA, van Diest PJ et al. Minimally invasive ablative therapies for invasive breast carcinomas: an overview of current literature. World J Surg 2007;31:2284-2292.
8
El-Tamer MB, Ward BM, Schifftner T et al. Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care. Ann Surg 2007;245:665-671.
9
Kontos M, Felekouras E, Fentiman IS. Radiofrequency ablation in the treatment of primary breast cancer: no surgical redundancies yet. Int J Clin Pract. 2008;62:816- 820.
10
Smeets JL, Rodriguez LM, Cheriex EC et al. Radiofrequency energy as treatment for arrhythmias in patients with accessory atrioventricular pathways.Ned Tijdschr Geneeskd. 1992;136:2131-2135.
11
Powell NB, Riley RW, Troell RJ et al. Radiofrequency volumetric tissue reduction of the palate in subjects with sleep-disordered breathing. Chest 1998;113:1163- 1174.
12
Wilkinson HA. Percutaneous radiofrequency upper thoracic sympathectomy. Neurosurgery 1996;38:715-725.
13
Baron MS, Vitek JL, Bakay RA et al. Treatment of advanced Parkinson's disease by unilateral posterior GPi pallidotomy: 4-year results of a pilot study. Mov Disord 2000;15:230-237.
14
Curley SA, Izzo F, Delrio P et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999;230:1-8.
15
Pearson AS, Izzo F, Fleming RY et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999;178:592-599.
16
Curley SA, Izzo F, Ellis LM et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381-391.
17
Zlotta AR, Djavan B, Matos C et al. Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer. Br J Urol 1998;81:265-275.
18
Zlotta AR, Wildschutz T, Raviv G et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol 1997;11:251-258.
19
Aliberti C, Soriani M, Tilli M et al. Radiofrequency ablation of liver malignancies: MRI for evaluation of response. J Chemother 2004;16 Suppl 5:79-81.
20
Rosenthal DI, Hornicek FJ, Wolfe MW et al. Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment. J Bone Joint Surg Am 1998;80:815-821.
21
Jeffrey SS, Birdwell RL, Ikeda DM et al. Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg 1999;134:1064-1068.
22
Izzo F, Thomas R, Delrio P et al. Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients. Cancer 2001;92:2036-2044.
23
Fornage BD, Sneige N, Ross MI et al. Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology 2004;231:215-224.
24
Noguchi M, Earashi M, Fujii H et al. Radiofrequency ablation of small breast cancer followed by surgical resection. J Surg Oncol 2006;93:120-128.
25
Khatri VP, McGahan JP, Ramsamooj R et al. A phase II trial of image-guided radiofrequency ablation of small invasive breast carcinomas: use of salinecooled tip electrode. Ann Surg Oncol 2007;14:1644-1652.
26
Medina-Franco H, Soto-Germes S, Ulloa- Gómez JL et al. Radiofrequency ablation of invasive breast carcinomas: a phase II trial. Ann Surg Oncol 2008;15:1689-1695.
27
Elliott RL, Rice PB, Suits JA et al. Radiofrequency ablation of a stereotactically localized nonpalpable breast carcinoma. Am Surg 2002;68:1-5.
28
Burak WE Jr, Agnese DM, Povoski SP, et al. Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision. Cancer 2003;98:1369- 1376.
29
Hayashi AH, Silver SF, van der Westhuizen NG et al. Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation. Am J Surg 2003;185:429-435.
30
Earashi M, Noguchi M, Motoyoshi A et al. Radiofrequency ablation therapy for small breast cancer followed by immediate surgical resection or delayed mammotome excision. Breast Cancer 2007;14:39-47.
31
Susini T, Nori J, Olivieri S et al. Radiofrequency ablation for minimally invasive treatment of breast carcinoma. A pilot study in elderly inoperable patients. Gynecol Oncol 2007;104:304-310.
32
Marcy PY, Magné N, Castadot P et al. Ultrasound-guided percutaneous radiofrequency ablation in elderly breast cancer patients: preliminary institutional experience. Br J Radiol 2007;80:267-273
33
Oura S, Tamaki T, Hirai I et al. Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size. Breast Cancer 2007;14:48-54.
34
Golshan M, Fung BB, Wiley E et al. Prediction of breast cancer size by ultrasound, mammography and core biopsy. Breast 2004;13:265-271.
35
Hata T, Takahashi H, Watanabe K, et al. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. J Am Coll Surg 2004;198:190-197.
36
Tillman GF, Orel SG, Schnall MD et al. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol 2002;20:3413-3423.
37
Morrow M. Magnetic resonance imaging in the preoperative evaluation of breast cancer: primum non nocere. J Am Coll Surg 2004;198:240-241.
38
Noguchi M. Is radiofrequency ablation treatment for small breast cancer ready for “prime time”?. Breast Cancer Res Treat 2007;106:307-314.
39
Bland KL, Gass J, Klimberg VS. Radiofrequency, cryoablation, and other modalities for breast cancer ablation. Surg Clin North Am 2007;87:539-550.
40
van den Bosch M, Daniel B, Rieke V et al. MRI-guided radiofrequency ablation of breast cancer: preliminary clinical experience. J Magn Reson Imaging 2008;27:204-208.
41
Hoorntje LE, Schipper ME, Peeters PH et al. The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma- in-situ: causes of ductal carcinomain- situ underestimates with stereotactic 14-gauge needle biopsy. Ann Surg Oncol 2003;10:748-753.
42
Jackman RJ, Nowels KW, Rodriguez-Soto J et al. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term followup. Radiology 1999;210:799-805.
43
Tamaki T, Oura S, Yoshimatsu T et al. Radiofrequency ablation therapy in 100 patients:its safety and short-term outcome. J Jpn Surg Assoc 2006 (Suppl) 67:305.
44
LaTrenta LR, Menell JH, Morris EA et al. Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. Radiology 2003;227:856-861.
